Back
Emergent BioSolutions Vs. FibroGen Industry Stock Comparison
Buy
72
EBS
Emergent BioSolutions
Last Price:
5.27
Seasonality Move:
6.46%
Sell
44
FGEN
FibroGen
Last Price:
1.24
Seasonality Move:
4.7%
Buy
72
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $5.71. The Score for EBS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- EBS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $1.19. The Score for FGEN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $5.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FGEN Stock Price Chart
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 82.65 | Buy |
| Chaikin Money Flow: | 1869990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.71 - 4.29) | Buy |
| Bollinger Bands (100): | (1.62 - 3.28) | Buy |
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 44.65 | Sell |
| Chaikin Money Flow: | -697942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.07 - 1.27) | Buy |
| Bollinger Bands (100): | (0.95 - 2.11) | Sell |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.71 | Buy |
| 20-day SMA: | 3.25 | Buy |
| 50-day SMA: | 2.73 | Buy |
| 200-day SMA: | 2.92 | Buy |
| 8-day EMA: | 4.68 | Buy |
| 20-day EMA: | 3.72 | Buy |
| 50-day EMA: | 2.99 | Buy |
| 200-day EMA: | 4.13 | Buy |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.2 | Sell |
| 20-day SMA: | 1.14 | Buy |
| 50-day SMA: | 1.6 | Sell |
| 200-day SMA: | 1.18 | Buy |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 1.23 | Sell |
| 50-day EMA: | 1.42 | Sell |
| 200-day EMA: | 3.07 | Sell |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.88 per share, and an increase next year of $0.85 per share.
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.19 per share, an increase this year of $1.74 per share, and an increase next year of $0.97 per share.
Emergent BioSolutions Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FibroGen Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||